Boston Scientific CorporationBSXNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank92
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P92
Near historical high
vs 2Y Ago
5.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.70% |
| Q3 2025 | -2.28% |
| Q2 2025 | 18.74% |
| Q1 2025 | -3.70% |
| Q4 2024 | 13.02% |
| Q3 2024 | 6.27% |
| Q2 2024 | 4.64% |
| Q1 2024 | 0.83% |
| Q4 2023 | 1.97% |
| Q3 2023 | -0.84% |
| Q2 2023 | 6.53% |
| Q1 2023 | 2.12% |
| Q4 2022 | -2.65% |
| Q3 2022 | 1.19% |
| Q2 2022 | 5.02% |
| Q1 2022 | -0.31% |
| Q4 2021 | 3.23% |
| Q3 2021 | 4.03% |
| Q2 2021 | 7.97% |
| Q1 2021 | -3.50% |
| Q4 2020 | -9.21% |
| Q3 2020 | 30.17% |
| Q2 2020 | -19.33% |
| Q1 2020 | -2.91% |
| Q4 2019 | 0.98% |
| Q3 2019 | 9.29% |
| Q2 2019 | 0.00% |
| Q1 2019 | -2.78% |
| Q4 2018 | -0.35% |
| Q3 2018 | 5.09% |
| Q2 2018 | 5.36% |
| Q1 2018 | -1.14% |
| Q4 2017 | 3.94% |
| Q3 2017 | 4.10% |
| Q2 2017 | 3.83% |
| Q1 2017 | -8.20% |
| Q4 2016 | 10.34% |
| Q3 2016 | 4.50% |
| Q2 2016 | 5.71% |
| Q1 2016 | -13.93% |